SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-026995
Filing Date
2021-05-12
Accepted
2021-05-12 16:11:16
Documents
63
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q kzr-10q_20210331.htm   iXBRL 10-Q 2096440
2 EX-31.1 kzr-ex311_8.htm EX-31.1 21305
3 EX-31.2 kzr-ex312_7.htm EX-31.2 21449
4 EX-32.1 kzr-ex321_6.htm EX-32.1 9199
5 GRAPHIC gzzdwzoli13m000001.jpg GRAPHIC 111966
  Complete submission text file 0001564590-21-026995.txt   7153379

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA kzr-20210331.xsd EX-101.SCH 47102
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kzr-20210331_cal.xml EX-101.CAL 42109
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kzr-20210331_def.xml EX-101.DEF 114044
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE kzr-20210331_lab.xml EX-101.LAB 339921
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kzr-20210331_pre.xml EX-101.PRE 256075
11 EXTRACTED XBRL INSTANCE DOCUMENT kzr-10q_20210331_htm.xml XML 1249884
Mailing Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-822-5600
Kezar Life Sciences, Inc. (Filer) CIK: 0001645666 (see all company filings)

IRS No.: 473366145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38542 | Film No.: 21915191
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences